Human papillomavirus immortalization and transformation functions.
暂无分享,去创建一个
[1] M. Scheffner,et al. Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins , 1993, Molecular and cellular biology.
[2] A. Berk,et al. Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein , 1992, Nature.
[3] P. Howley,et al. Bovine papillomavirus type 1 3' early region transformation and plasmid maintenance functions , 1986, Journal of virology.
[4] C. Meyers,et al. The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties , 1990, Journal of virology.
[5] David Beach,et al. p21 is a universal inhibitor of cyclin kinases , 1993, Nature.
[6] T. Noda,et al. Identification of a transforming gene of human papillomavirus type 16 , 1989, Journal of virology.
[7] S. Elledge,et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.
[8] P. Yaciuk,et al. TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains , 1990, Cell.
[9] D. McCance,et al. The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes , 1995, Journal of virology.
[10] A. Levine,et al. Association of human papillomavirus types 16 and 18 E6 proteins with p53. , 1990, Science.
[11] D. DiMaio,et al. 44-amino-acid E5 transforming protein of bovine papillomavirus requires a hydrophobic core and specific carboxyl-terminal amino acids , 1988, Molecular and cellular biology.
[12] S. Caldeira,et al. Induction of pRb Degradation by the Human Papillomavirus Type 16 E7 Protein Is Essential To Efficiently Overcome p16INK4a-Imposed G1 Cell Cycle Arrest , 2001, Journal of Virology.
[13] M. Stanley,et al. Lack of immortalizing activity of a human papillomavirus type 16 variant DNA with a mutation in the E2 gene isolated from normal human cervical keratinocytes. , 1992, Oncogene.
[14] M. Barbosa,et al. Single amino acid substitutions in "low-risk" human papillomavirus (HPV) type 6 E7 protein enhance features characteristic of the "high-risk" HPV E7 oncoproteins. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[15] M. O’Connor,et al. The Human Papillomavirus Type 16 E6 Oncoprotein Can Down-Regulate p53 Activity by Targeting the Transcriptional Coactivator CBP/p300 , 1999, Journal of Virology.
[16] H. Pitot,et al. The Human Papillomavirus Type 16 E6 Gene Alone Is Sufficient To Induce Carcinomas in Transgenic Animals , 1999, Journal of Virology.
[17] D. Lowy,et al. The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation. , 1990, The EMBO journal.
[18] N. Fusenig,et al. Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. , 1987, Oncogene.
[19] K. Münger,et al. The Cytokines Tumor Necrosis Factor-α (TNF-α) and TNF-related Apoptosis-inducing Ligand Differentially Modulate Proliferation and Apoptotic Pathways in Human Keratinocytes Expressing the Human Papillomavirus-16 E7 Oncoprotein* , 2001, The Journal of Biological Chemistry.
[20] P. Howley,et al. Human Papillomavirus Type 16 E6 Induces Self-Ubiquitination of the E6AP Ubiquitin-Protein Ligase , 2000, Journal of Virology.
[21] K. Münger,et al. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. , 1989, The EMBO journal.
[22] P. Howley,et al. The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[23] T. Kanda,et al. Immortalization of primary rat cells by human papillomavirus type 16 subgenomic DNA fragments controlled by the SV40 promoter. , 1988, Virology.
[24] P. Howley,et al. The Role of E6AP in the Regulation of p53 Protein Levels in Human Papillomavirus (HPV)-positive and HPV-negative Cells* , 1998, The Journal of Biological Chemistry.
[25] T. Iftner,et al. Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1 , 1994, Journal of virology.
[26] N. Jareborg,et al. Localization of bovine papillomavirus type 1 E5 protein to transformed basal keratinocytes and permissive differentiated cells in fibropapilloma tissue. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[27] J. Settleman,et al. Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene , 1993, Journal of virology.
[28] S. S. Lee,et al. Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[29] J. Schneider,et al. Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells. , 1987, The EMBO journal.
[30] P. Beer-Romero,et al. Antisense targeting of E6AP elevates p53 in HPV-infected cells but not in normal cells , 1997, Oncogene.
[31] T. Kanda,et al. Human papillomavirus type 16 transformation of primary human embryonic fibroblasts requires expression of open reading frames E6 and E7 , 1989, Journal of virology.
[32] M. Scheffner,et al. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. , 1991, The EMBO journal.
[33] M. Willingham,et al. The E5 oncoprotein of bovine papillomavirus is oriented asymmetrically in Golgi and plasma membranes. , 1989, Virology.
[34] M. Botchan,et al. Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV-1 genome. , 1989, Genes & development.
[35] D. E. Groff,et al. Genetic analysis of the 3' early region transformation and replication functions of bovine papillomavirus type 1. , 1986, Virology.
[36] Santhosh K. P. Kumar,et al. Regulation of the Src family tyrosine kinase Blk through E6AP-mediated ubiquitination. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[37] K. Yoshiike,et al. Transformation of rat 3Y1 cells by human papillomavirus type‐18 DNA , 1988, International journal of cancer.
[38] D. Lowy,et al. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. , 1989, The EMBO journal.
[39] Kathleen R. Cho,et al. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[40] T. Crook,et al. Corrigendum: Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription (The EMBO Journal(1992)11(3045-3052)) , 1992 .
[41] T. Crook,et al. Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53‐mediated repression of transcription. , 1992, The EMBO journal.
[42] E. Harlow,et al. Cellular targets for transformation by the adenovirus E1A proteins , 1989, Cell.
[43] W. Zwerschke,et al. Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. , 1996, Oncogene.
[44] K. Münger,et al. Degradation of the Retinoblastoma Tumor Suppressor by the Human Papillomavirus Type 16 E7 Oncoprotein Is Important for Functional Inactivation and Is Separable from Proteasomal Degradation of E7 , 2001, Journal of Virology.
[45] S. Grossman,et al. Intracellular localization and DNA-binding properties of human papillomavirus type 18 E6 protein expressed with a baculovirus vector , 1989, Journal of virology.
[46] J. DiPaolo,et al. Human papillomavirus type 16 DNA-induced malignant transformation of NIH 3T3 cells , 1986, Journal of virology.
[47] K. Münger,et al. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[48] J. Schiller,et al. Human papillomavirus type 16 E6 increases the degradation rate of p53 in human keratinocytes , 1992, Journal of virology.
[49] J. Huibregtse,et al. Human Scribble (Vartul) Is Targeted for Ubiquitin-Mediated Degradation by the High-Risk Papillomavirus E6 Proteins and the E6AP Ubiquitin-Protein Ligase , 2000, Molecular and Cellular Biology.
[50] P. Howley,et al. Identification of HHR23A as a Substrate for E6-associated Protein-mediated Ubiquitination* , 1999, The Journal of Biological Chemistry.
[51] A. Levine,et al. Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53 , 1983, Molecular and cellular biology.
[52] D. Lowy,et al. Papillomavirus polypeptides E6 and E7 are zinc-binding proteins , 1989, Journal of virology.
[53] G. Nuovo,et al. Isolation of a novel human papillomavirus (type 51) from a cervical condyloma , 1988, Journal of virology.
[54] V. Garsky,et al. Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein , 1993, Molecular and cellular biology.
[55] D. Pim,et al. Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth , 1997, Oncogene.
[56] M. Scheffner,et al. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 , 1993, Cell.
[57] Stephen H. Friend,et al. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product , 1988, Nature.
[58] L. Tsai,et al. Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[59] D. McCance,et al. Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes , 1992, Journal of virology.
[60] Wen-Hwa Lee,et al. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene , 1988, Cell.
[61] M. von Knebel Doeberitz,et al. Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. , 1988, Cancer research.
[62] M. Yutsudo,et al. Functional dissociation of transforming genes of human papillomavirus type 16. , 1988, Virology.
[63] K. Münger,et al. The human papillomavirus E7 oncoprotein and the cellular transcription factor E2F bind to separate sites on the retinoblastoma tumor suppressor protein , 1993, Journal of virology.
[64] K. Münger,et al. Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype. , 2001, Cancer research.
[65] R. Schlegel,et al. The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein , 1993, Journal of virology.
[66] S. Beaudenon,et al. Plurality of genital human papillomaviruses: characterization of two new types with distinct biological properties. , 1987, Virology.
[67] A. Ciechanover,et al. Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue , 2000, Oncogene.
[68] H. Pan,et al. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. , 1994, Genes & development.
[69] K. Kinzler,et al. Oncogenic forms of p53 inhibit p53-regulated gene expression , 1992 .
[70] E. Fuchs,et al. Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[71] P. Howley,et al. The transcriptional transactivation function of wild‐type p53 is inhibited by SV40 large T‐antigen and by HPV‐16 E6 oncoprotein. , 1992, The EMBO journal.
[72] K. Münger,et al. Centrosome Abnormalities and Genomic Instability by Episomal Expression of Human Papillomavirus Type 16 in Raft Cultures of Human Keratinocytes , 2001, Journal of Virology.
[73] M. Scheffner,et al. A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[74] K. Münger,et al. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. , 1989, Science.
[75] L. Banks,et al. Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation , 1999, Oncogene.
[76] F. Carlotti,et al. Functional studies of E7 proteins from different HPV types. , 1994, Oncogene.
[77] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[78] D. Wazer,et al. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. , 1996, Cancer research.
[79] K. Münger,et al. Centrosome abnormalities, genomic instability and carcinogenic progression. , 2001, Biochimica et biophysica acta.
[80] V. Band,et al. Loss of p53 protein in human papillomavirus type 16 E6-immortalized human mammary epithelial cells , 1991, Journal of virology.
[81] A. Alonso,et al. Binding of human papillomavirus 16 E5 to the 16 kDa subunit c (proteolipid) of the vacuolar H+-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation , 2000, Oncogene.
[82] D. McCance,et al. The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes , 1993, Journal of virology.
[83] Karl Münger,et al. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein , 2001, Oncogene.
[84] R. Schlegel,et al. The E5 transforming gene of bovine papillomavirus encodes a small, hydrophobic polypeptide. , 1986, Science.
[85] E. Flores,et al. The Human Papillomavirus Type 16 E7 Oncogene Is Required for the Productive Stage of the Viral Life Cycle , 2000, Journal of Virology.
[86] A. Levine,et al. Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells , 1981, Molecular and cellular biology.
[87] D. Wazer,et al. Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[88] P. Howley,et al. Structure of an E6AP-UbcH7 complex: insights into ubiquitination by the E2-E3 enzyme cascade. , 1999, Science.
[89] A. Ciechanover,et al. The ubiquitin system. , 1998, Annual review of biochemistry.
[90] R. Weinberg,et al. The retinoblastoma protein and the regulation of cell cycling. , 1992, Trends in biochemical sciences.
[91] K. Münger,et al. Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein , 1992, Journal of virology.
[92] D. DiMaio,et al. Tumorigenic transformation of murine keratinocytes by the E5 genes of bovine papillomavirus type 1 and human papillomavirus type 16 , 1991, Journal of virology.
[93] K. Münger,et al. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A , 1988, Cell.
[94] T. Tlsty,et al. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. , 1994, Genes & development.
[95] D. Galloway,et al. Destabilization of the Retinoblastoma Tumor Suppressor by Human Papillomavirus Type 16 E7 Is Not Sufficient To Overcome Cell Cycle Arrest in Human Keratinocytes , 2001, Journal of Virology.
[96] D. DiMaio,et al. The platelet-derived growth factor beta receptor as a target of the bovine papillomavirus E5 protein. , 2000, Cytokine & growth factor reviews.
[97] K. Vousden,et al. A point mutational analysis of human papillomavirus type 16 E7 protein , 1989, Journal of virology.
[98] B. Stillman,et al. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. , 1997, Genes & development.
[99] D. Lowy,et al. The E7 open reading frame of human papillomavirus type 16 encodes a transforming gene. , 1988, Oncogene research.
[100] E. Auvinen,et al. Enhancement of EGF- and PMA-mediated MAP kinase activation in cells expressing the human papillomavirus type 16 E5 protein , 1997, Oncogene.
[101] P. Howley,et al. Physical Interaction between Specific E2 and Hect E3 Enzymes Determines Functional Cooperativity* , 1997, The Journal of Biological Chemistry.
[102] K. Münger,et al. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. , 1997, Genes & development.
[103] J. Shay,et al. A transcriptionally active DNA-binding site for human p53 protein complexes , 1992, Molecular and cellular biology.
[104] C. Woodworth,et al. Characterization of Normal Human Exocervical Epithelial Cells Immortalized in Vitro by Papillonâ „ ¢ virusTypes 16 and 18 DNA 1 , 2006 .
[105] J. McDougall,et al. Characterization of primary human keratinocytes transformed by human papillomavirus type 18 , 1988, Journal of virology.
[106] K. Münger,et al. The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[107] D. DiMaio,et al. Genetic and biochemical definition of the bovine papillomavirus E5 transforming protein. , 1987, The EMBO journal.
[108] Martin Scheffner,et al. Protein ubiquitination involving an E1–E2–E3 enzyme ubiquitin thioester cascade , 1995, Nature.
[109] T. R. Broker,et al. Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. , 1995, Genes & development.
[110] S. Grossman,et al. E6 protein of human papillomavirus type 18 binds zinc. , 1989, Oncogene.
[111] D. Lowy,et al. E5 open reading frame of bovine papillomavirus type 1 encodes a transforming gene , 1986, Journal of virology.
[112] P. Howley,et al. Repression of the Integrated Papillomavirus E6/E7 Promoter Is Required for Growth Suppression of Cervical Cancer Cells , 2000, Journal of Virology.
[113] J. McDougall,et al. Telomerase activation by the E6 gene product of human papillomavirus type 16 , 1996, Nature.
[114] D. DiMaio,et al. Translation of open reading frame E5 of bovine papillomavirus is required for its transforming activity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[115] C. Turner,et al. Association of Bovine Papillomavirus Type 1 E6 oncoprotein with the focal adhesion protein paxillin through a conserved protein interaction motif , 1998, Oncogene.
[116] R. Brent,et al. Dimerization of the human papillomavirus E7 oncoprotein in vivo. , 1995, Virology.
[117] L. Banks,et al. The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus. , 1992, Oncogene.
[118] Arnold J. Levine,et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.
[119] P. Howley,et al. Suppression of cellular proliferation by the papillomavirus E2 protein , 1995, Journal of virology.
[120] M. von Knebel Doeberitz,et al. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene. , 1996, Oncogene.
[121] D. Lowy,et al. The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture , 1991, Journal of virology.
[122] A. Ciechanover,et al. Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[123] J. Mazzarelli,et al. Oligomerization properties of the viral oncoproteins adenovirus E1A and human papillomavirus E7 and their complexes with the retinoblastoma protein. , 2000, Biochemistry.
[124] M. Scheffner,et al. Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53 , 1993, Molecular and cellular biology.
[125] D. Pim,et al. Comparison of the in vitro transforming activities of human papillomavirus types. , 1988, The EMBO journal.
[126] K. Münger,et al. Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein , 1997, Journal of virology.
[127] M. Yaniv,et al. Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis , 1997, The EMBO journal.
[128] S. Cole,et al. Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products. , 1987, Journal of molecular biology.
[129] H. Sato,et al. Expression of human papillomavirus type 16 E7 gene induces DNA synthesis of rat 3Y1 cells. , 1989, Virology.
[130] K. Münger,et al. Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[131] D. Albert,et al. Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. , 1994, Genes & development.
[132] D. Patel,et al. The E6 protein of human papillomavirus type 16 binds to and inhibits co‐activation by CBP and p300 , 1999, The EMBO journal.
[133] J. D. Benson,et al. Papillomavirus E2 induces senescence in HPV‐positive cells via pRB‐ and p21CIP‐dependent pathways , 2000, The EMBO journal.
[134] R. Schlegel,et al. Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma. , 1988, The EMBO journal.
[135] M Fujita,et al. Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[136] L. Banks,et al. E3-Ubiquitin Ligase/E6-AP Links Multicopy Maintenance Protein 7 to the Ubiquitination Pathway by a Novel Motif, the L2G Box* , 1998, The Journal of Biological Chemistry.
[137] J. DiPaolo,et al. Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA , 1987, Journal of virology.
[138] A. Levine,et al. Surfing the p53 network , 2000, Nature.
[139] J. T. Thomas,et al. Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[140] R. Schlegel,et al. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes , 1989, Journal of virology.
[141] M. Yaniv,et al. The BPV1‐E2 trans‐acting protein can be either an activator or a repressor of the HPV18 regulatory region. , 1987, The EMBO journal.
[142] L. Banks,et al. Multi-PDZ Domain Protein MUPP1 Is a Cellular Target for both Adenovirus E4-ORF1 and High-Risk Papillomavirus Type 18 E6 Oncoproteins , 2000, Journal of Virology.